← Leaderboards
Gregorio Valdez
Harvard University
$5,120,222
Attributed
$5,404,462
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $724.1K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,404,462 · 9
By mechanism
R01$2,171,178 · 1
R56$1,097,805 · 3
R21$871,471 · 2
K01$679,068 · 1
T32$426,360 · 1
F32$158,580 · 1
Top collaborators
- Mark Aikens Johnson1 shared
- Erica Nicole Larschan1 shared
Most similar at Harvard University
Same institution · by research overlap
- David J Mooney$45,709,587
- Lauren Anne Litzau$77,085
- Brian A Link$13,275,633
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMolecularAffectMouse ModelSynapsesAxonPreventNeuromuscular JunctionAmyotrophic Lateral SclerosisAge RelatedAgingNormal AgingMuscleMotor NeuronsRepairedSignal TransductionDesignPlayPublishingMotorCessation Of LifeExperimental StudyMotor DeficitBase
Grant awards (23)
Predoctoral Training in Molecular, Cellular, and Biochemical Sciences$426,360
T32 · FY2025 · GM
Development of a microbial-rich exposure regimen to accelerate translational research using mouse models of Alzheimer's Disease to humans.$239,250
R21 · FY2024 · AG · contact PI
Development of a microbial-rich exposure regimen to accelerate translational research using mouse models of Alzheimer's Disease to humans.$199,375
R21 · FY2023 · AG · contact PI
Role of synaptic Schwann cells in NMJ and skeletal muscle aging$326,975
R56 · FY2022 · AG · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$326,619
R01 · FY2021 · AG · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$396,250
R01 · FY2020 · AG · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$326,899
R01 · FY2020 · AG · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$266,500
R01 · FY2019 · AG · contact PI
Analysis of Sensory Neurons to Understand and Identify Factors to Treat ALS$159,144
R21 · FY2019 · NS · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$66,010
R01 · FY2019 · AG · contact PI
Analysis of sensory neurons to understand and identify factors to treat ALS$39,786
R21 · FY2019 · NS · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$330,050
R01 · FY2018 · AG · contact PI
Analysis of sensory neurons to understand and identify factors to treat ALS$233,916
R21 · FY2018 · NS · contact PI
Administrative Supplement: Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$128,800
R01 · FY2018 · AG · contact PI
Dysregulated cholinergic transmission contributes to aging of the lower motor system$394,011
R56 · FY2017 · AG · contact PI
Targeting the fibroblast growth factor binding protein-1 to slow degeneration of neuromuscular junctions$330,050
R01 · FY2017 · AG · contact PI
Synaptic FGFs are required and sufficient to maintain and repair aged NMJs$376,819
R56 · FY2015 · AG · contact PI
Role of Target-derived FGFs in Maintaining and Repairing Synapses$226,356
K01 · FY2015 · NS · contact PI
Role of Target-derived FGFs in Maintaining and Repairing Synapses$226,356
K01 · FY2014 · NS · contact PI
Role of Target-derived FGFs in Maintaining and Repairing Synapses$226,356
K01 · FY2013 · NS · contact PI
Molecular basis of age-related synaptic alterations$53,948
F32 · FY2010 · NS · contact PI
Molecular basis of age-related synaptic alterations$53,354
F32 · FY2009 · NS · contact PI
Molecular basis of age-related synaptic alterations$51,278
F32 · FY2008 · NS · contact PI